Australia markets closed

Panbela Therapeutics, Inc. (PBLA)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.4102+0.0289 (+7.58%)
At close: 03:52PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
20,614
20,614
28,049
5,423
2,505
Selling general and administrative
5,033
5,033
6,044
4,587
3,249
Total operating expenses
25,647
25,647
34,093
10,010
5,754
Operating income or loss
-25,647
-25,647
-34,093
-10,010
-5,754
Interest expense
317
317
288
12
17
Total other income/expenses net
392
392
-682
-602
708
Income before tax
-25,449
-25,449
-35,049
-10,623
-5,063
Income tax expense
-186
-186
-116
-488
-295
Income from continuing operations
-25,263
-25,263
-34,933
-10,135
-4,768
Net income
-25,263
-25,263
-34,933
-10,135
-4,768
Net income available to common shareholders
-25,263
-25,263
-34,933
-10,135
-4,768
Basic EPS
-157.02
-316.52
-19.97k
-18.10k
-11.86k
Diluted EPS
-157.02
-316.52
-19.97k
-18.10k
-11.86k
Basic average shares
149.816
108.691
1.749
0.56
0.402
Diluted average shares
149.816
108.691
1.749
0.56
0.402